Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), a leading global medical cannabis company, has announced its upcoming second quarter 2025 earnings conference call scheduled for Wednesday, November 6, 2024, at 8:00 a.m. Eastern Time. The financial results will be released before market opening on the same day. Chairman and CEO Miguel Martin and CFO Simona King will host the conference call and Q&A session.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), una delle principali aziende globali nel settore della cannabis medica, ha annunciato la sua prossima conferenza telefonica sui risultati finanziari del secondo semestre 2025, programmata per mercoledì 6 novembre 2024, alle 8:00 ora orientale. I risultati finanziari saranno pubblicati prima dell'apertura del mercato lo stesso giorno. Il Presidente e CEO Miguel Martin e il CFO Simona King guideranno la conferenza telefonica e la sessione di domande e risposte.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), una de las principales empresas de cannabis médica a nivel mundial, ha anunciado su próxima conferencia telefónica sobre los resultados del segundo trimestre de 2025, programada para el miércoles 6 de noviembre de 2024, a las 8:00 a.m. hora del este. Los resultados financieros se publicarán antes de la apertura del mercado el mismo día. El presidente y CEO Miguel Martin y la CFO Simona King serán los encargados de la conferencia telefónica y de la sesión de preguntas y respuestas.
오로라 캐나비스 (NASDAQ: ACB) (TSX: ACB)는 세계적인 의료용 대마초 회사로, 2025년 2분기 실적 컨퍼런스 콜을 2024년 11월 6일 수요일 오전 8시 동부 표준시에 예정하고 있음을 발표했습니다. 재무 결과는 같은 날 시장 개장 전에 발표될 것입니다. 회장 겸 CEO 미겔 마르틴과 CFO 시모나 킹이 컨퍼런스 콜 및 질문과 응답 세션을 주최할 예정입니다.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), une entreprise mondiale leader dans le domaine du cannabis médical, a annoncé sa prochaine conférence téléphonique sur les résultats du deuxième trimestre 2025, prévue pour mercredi 6 novembre 2024, à 8h00, heure de l'Est. Les résultats financiers seront publiés avant l'ouverture du marché le même jour. Le président et CEO Miguel Martin et la CFO Simona King animeront la conférence téléphonique et la séance de questions-réponses.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), ein führendes globales Unternehmen im Bereich medizinisches Cannabis, hat seine bevorstehende Telefonkonferenz zu den Ergebnissen des zweiten Quartals 2025 angekündigt, die für Mittwoch, den 6. November 2024, um 8:00 Uhr Ostküstenzeit angesetzt ist. Die finanziellen Ergebnisse werden am selben Tag vor der Markteröffnung veröffentlicht. Vorsitzender und CEO Miguel Martin sowie CFO Simona King werden die Telefonkonferenz und die Frage-Antwort-Runde leiten.
- None.
- None.
NASDAQ | TSX: ACB
Conference Call Details
DATE: | Wednesday, November 6, 2024 |
TIME: | 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time |
WEBCAST: |
Miguel Martin, Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events".
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both the medical and consumer markets across
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
For Media: | For Investors: |
Michelle Lefler | ICR, Inc. |
VP, Communications & PR | Investor Relations |
Forward Looking Statements
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing for the release of the Company's Fiscal 2025 Q2 financial statements and the conference call to discuss the results.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in
View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-second-quarter-2025-investor-conference-call-302286648.html
SOURCE Aurora Cannabis Inc.
FAQ
When will Aurora Cannabis (ACB) report its Q2 2025 earnings?
What time is Aurora Cannabis (ACB) Q2 2025 earnings call?